Skip to main content
Equibles

DRUG · Bright Minds Biosciences Inc.

Track DRUG — free

Use DRUG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DRUG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$54.35 +0.30 (+0.56%)
Russell 2000 member Rebalance outlook locked
Market Cap
$533.15M
Shares
9.86M
Volume · Oct 12 3509 Avg daily vol (3M) 158.1K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$54.05 Open$52.45 Day$51.91–55.78 52W close$48.25–95.99 Avg vol 30d115K Short int883K · 8.9% float · 8.5d Short vol57% Last earningsJan 6, 2026 DataMar 2021–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-12.0%
Trailing year
Short interest
8.9%
Latest settlement · 8.5 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 14.8 · calm Equity put/call 0.56
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −29%
below
Price vs 50-day avg −19%
below
RSI (14) 42
neutral
MACD trend Positive
52-week position 12%
near low
Momentum
relative strength
Very Weak
1-month return −14%
trailing
6-month return −40%
trailing
YTD return −31%
this year
Relative strength −50%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $67 › 200d $76 — 200d above 50d
Institutional flow Accumulating
4 of 99 funds reported for Sep 30 · net +75 sh shares · +3 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
8.95% of float · ▼ -5.3% MoM · 8.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
99 holders — near 3-yr high, broad support
Squeeze score 61
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 63%
annualized · 1-yr
Max drawdown −50%
past year
ATR 6.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−29% Bearish
Price vs 50-day avg
−19% Bearish
RSI (14)
42 Neutral
MACD trend
Positive Bullish
52-week position
12% Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $67 › 200d $76 — 200d above 50d
Institutional flow Accumulating
4 of 99 funds reported for Sep 30 · net +75 sh shares · +3 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
8.95% of float · ▼ -5.3% MoM · 8.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
99 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $48 Now $54 · 12% Range high $96
vs 200-day avg -29% vs 50-day avg -19%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DRUG
Bright Minds Biosciences Inc.
this stock
$533.15M -30.7% — — 8.9%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $129.29B +12.5% +46.2% 29.7 1.8%
MRNA
Moderna, Inc.
 $89.83B +663.0% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $76.86B -3.3% +20.8% 18.5 2.1%
CSLLY
Csl Ltd
 $61.83B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
102
% held
94.4%
Reported
4 of 99
Top holder
Jupiter Topco LLC
Held Float
View
Held by Funds
Fund positions
91
View
Short & Settlement
Short Interest Falling
Shares short
882.8K
Days to cover
8.5d
Change
-49.1K sh
View
Short Volume
Short vol %
57%
As of
Oct 9, 2026
Short Total
View
Fails to Deliver
FTD shares
4.7K
Value
$308.1K
As of
Sep 8, 2026
View
Off-Exchange
Off-exchange %
52.6%
Week of
Sep 7, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 2, 2026
This year
15
View
Exempt Offerings
Offering
$34.6M
Filed
Nov 19, 2024
View
Earnings & Events
Webcasts
Last webcast
Jan 6, 2026
View

Performance

5D 20D 120D MTD YTD
DRUG +6.6% -14.5% -40.5% +8.5% -30.7%
SPY +1.2% +1.9% +9.9% +2.1% +14.2%
vs SPY +5.5% -16.3% -50.3% +6.4% -44.9%
Key facts CIK 1827401 CUSIP 10919W405 13F (30d) 5 filings 5 filers Visit website Investor relations